Close
Solutions
Online Inquiry
Global Services

Third Generation of CARs Design

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

As a leading provider of Chimeric antigen receptors (CARs) products, Creative Biolabs provides unparalleled CellRapeutics™ third generation CARs design to satisfy various customers' needs. We completely understand the challenge in constructing CARs. Thankfully, with an excellent and efficient team, and advanced techniques, we have successfully built up an solid platform for CARs construction.

Third Generation of CARs Design

From The Scientists. The CAR T-Cell Race by Vicki Brower on April 1, 2015.

Generally, the third generation CARs consist of an antigen binding unit, a spacer, a transmembrane domain and endodamain(s) the same as first or second-generations. The difference between the third generation and other generations is the co-stimulatory signaling domain, which composed of two different co-stimulatory signaling units in the intracellular regions besides the CD3ζ or FcεRIγ signaling domain. The major advantage of the third generation CARs is that it can induce high level cytokine secretion and significantly increase proliferation speed and survival rate of engrafted T cells. Our skilled scientists have constructed a variety of chimeric antigen receptors with signaling components such as CD28, CD137 (4-1BB), CD134 (OX40) and DAP10.

Creative Biolabs has established and developed world-renowned platform for CAR design, which can provide a superb service for every customer. With the solid reputation as a best-class services provider, we guarantee that CARs products from Creative Biolabs can greatly accelerate your project.

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.